WASHINGTON () – A U.S. court on Friday expelled Martin Shkreli from the pharmaceutical industry for life and forced him to pay $ 64.6 million for raising the price of Daraprim and fighting to keep general competitors out of the market.
The U.S. Federal Trade Commission and seven-state Viera Pharmaceuticals founder Shkreli have accused Daraprim of using illegal tactics to bring competitors to market after raising the price from $ 17.50 to $ 750. 2015.
The drug is used to treat toxoplasmosis, a parasitic infection that threatens people with weakened immune systems.
Shkreli, who is serving a seven-year prison sentence for securities fraud, did not attend the trial.